The first of three already conducted clinical pilots, relate to using MoreNova for female Sexual Improvement and Stress Urinary Incontinence. The pilots presented at the International Continence Society (ICS) 2021 Melbourne conference.  

Vaginal treatment is the latest desirable treatment to be offered by Morenova.
Packed as a table-top, compact and lightweight device, MoreNova provides treatment for various ailments and chronic diseases long suffered by women.

MoreNova Turbo (MT) is a shockwaves device incorporating a compact and powerful energizer, in-line ultrasound localizer and easily interchangeable high-efficiency applicators.

The novel applicators are designed to respectively deliver point, linear or planar shockwaves compatible with treating urinary stones, calcified leg arteries, prostate, Chronic Kidney Disease (CKD) and more.

An exclusive and limited offer is presently being offered to clinics interested in offering treatment.
Demo proposal is for a three month period and incorporates minimum 10 patient treatments, of 10 short sessions in 5 days, and follow-up p/p.

A description of Shockwaves and PEMF relationship is presented

DirexGroup announces MoreNova's registration in the U.S. as a Class I device for treating minor aches and pains. 

Efficacy of ESWL Lower Urether as an Alternative to Endoscopic Treatment is being presented Friday at 13:30 at the EAU Section of Urolithiasis (EULIS) conference, taking place in Milan, Italy from October 3-5, 2019.

We wish to congratulate Dr. Gatkin, and his team, on their latest paper which was accepted for the upcoming 5th Meeting of the EAU Section of Urolithiasis (EULIS), which is being held on 3-5 October 2019, Milan, Italy.

A recent Meta-analysis, published in the International Urology and Nephrology Journal and authored by leading physicians from Kings College and University College in London, reviewed long-term efficacy of low-intensity shockwave therapy for Vasculogenic Erectile Dysfunction.

The study was presented at the American Urological Association Annual Scientific Meeting held May 3-6, 2019 at the McCormick Center in Chicago.  The study was performed by   Dr. Lu Mujun of Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai , China.